GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. 

The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.

Biotechnology

Life Sciences

Pharmaceutical

Therapeutics

GC Therapeutics

Parastoo Khoshakhlagh

Cory Smith

Alex Ng

Kathryn Swiderski

Muhan Li

The Leadership Team at GC Therapeutics (GCTx) is responsible for setting the strategic direction, overseeing research and development, and ensuring the successful execution of the company's vision to revolutionize cell therapy. Comprising the CEO, Chief Scientific Officer, Principal Research Associate, and Head of Discovery Platforms, this team leverages their expertise in synthetic biology and tissue engineering to drive innovation, validate technologies, and bring transformative treatments to patients.

Leadership Team

Scientific Research and Development

Leadership Team

About

Team members

Other teams at GC Therapeutics

Scientific Research and Development